Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-22

Clinical Trial Update: Citrate Anticoagulation in Renal Replacement Therapy: Impact of a High Post-filter Calcium Target on Efficacy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating citrate anticoagulation for renal replacement therapy examined whether a higher post-filter calcium target improves efficacy. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Citrate anticoagulation solution for renal replacement therapy (trisodium citrate)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Renal Replacement Therapy | Phase 3 | Status: COMPLETED